• Synexus has expanded its global presence with the acquisition of a specialist clinical trial site close to Cape Town’s international airport.
  • Synexus, has been identified as a top player in the prestigious annual Sunday Times HSBC International Track 200 league table, published on Sunday, 13 July, 2014.
  • Synexus has been identified as a Hyper Growth business by GrowthAccelerator the government backed business growth advisory service.
  • Synexus opens a new clinical research centre in Bochum, Germany
  • Synexus announces clinical trial partnership with Northumbria Healthcare
  • Synexus continues to build in Eastern Europe, opening a new regional center to support global clinical trials
  • Synexus strengthens its global management team

Who we are

Synexus, headquartered in Manchester, continues to pioneer important developments in the clinical trials industry. Through a global network of 24 Dedicated Research Centres (DRCs) in nine countries Synexus provides first class clinical trials data to its clients from pharma, biotechs and CROs.

More about Synexus

What We Do

Synexus recruits patients and runs clinical trials at its own Dedicated Research Centres staffed by full time GCP investigators who work solely on clinical trials. The Synexus model has been designed to:

  • Speed up clinical trials
  • Reduce costs
  • Provide access to millions of patients worldwide

Who We Work For

You will need to download the flash player to view this content.

Synexus’ client base comprises some of the world's leading pharma, biotechs and CROs.   

More about our clients

Our Expertise

Synexus' expertise across a growing number of therapy areas is ensuring clients reach the agreed number of patients, on time and at a competitive cost. 

More about therapy areas

Synexus Limited, Registered in England and Wales, Registered number 3724238, Registered Office: Sandringham House, Ackhurst Park, Chorley , Lancashire, PR7 1NY